Lorenzo Bertani

2.4k total citations
80 papers, 1.4k citations indexed

About

Lorenzo Bertani is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Lorenzo Bertani has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 33 papers in Epidemiology and 29 papers in Surgery. Recurrent topics in Lorenzo Bertani's work include Inflammatory Bowel Disease (39 papers), Microscopic Colitis (30 papers) and Eosinophilic Esophagitis (17 papers). Lorenzo Bertani is often cited by papers focused on Inflammatory Bowel Disease (39 papers), Microscopic Colitis (30 papers) and Eosinophilic Esophagitis (17 papers). Lorenzo Bertani collaborates with scholars based in Italy, United States and Switzerland. Lorenzo Bertani's co-authors include Santino Marchi, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Edoardo Savarino, Linda Ceccarelli, M.G. Mumolo, Gherardo Tapete, Vincenzo Savarino and Eleonora Albano and has published in prestigious journals such as Gastroenterology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Lorenzo Bertani

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorenzo Bertani Italy	21	614	521	515	397	257	80	1.4k
Aydan Kansu Türkiye	20	365 0.6×	266 0.5×	367 0.7×	392 1.0×	235 0.9×	120	1.2k
Gian Luigi De’ Angelis Italy	22	801 1.3×	313 0.6×	289 0.6×	239 0.6×	226 0.9×	55	1.5k
Andrew Poullis United Kingdom	17	412 0.7×	455 0.9×	203 0.4×	404 1.0×	113 0.4×	75	1.1k
G. K. T. Holmes United Kingdom	13	487 0.8×	414 0.8×	355 0.7×	447 1.1×	168 0.7×	17	1.3k
Jonathon Snook United Kingdom	16	347 0.6×	315 0.6×	361 0.7×	455 1.1×	140 0.5×	42	1.2k
Oren Ledder Israel	20	484 0.8×	724 1.4×	154 0.3×	474 1.2×	168 0.7×	72	1.3k
Zoltán Szepes Hungary	20	565 0.9×	541 1.0×	159 0.3×	425 1.1×	286 1.1×	143	1.3k
Mamoun Elawad United Kingdom	19	390 0.6×	491 0.9×	163 0.3×	239 0.6×	565 2.2×	55	1.4k
Arthur Barrie United States	24	454 0.7×	961 1.8×	156 0.3×	813 2.0×	253 1.0×	84	1.6k
Nasir Mahmud Ireland	17	357 0.6×	381 0.7×	268 0.5×	282 0.7×	230 0.9×	33	1.1k

Countries citing papers authored by Lorenzo Bertani

Since Specialization

Citations

This map shows the geographic impact of Lorenzo Bertani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Bertani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Bertani more than expected).

Fields of papers citing papers by Lorenzo Bertani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Bertani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Bertani. The network helps show where Lorenzo Bertani may publish in the future.

Co-authorship network of co-authors of Lorenzo Bertani

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Bertani. A scholar is included among the top collaborators of Lorenzo Bertani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Bertani. Lorenzo Bertani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertani, Lorenzo, Davide Giuseppe Ribaldone, Fabrizio Bossa, et al.. (2025). When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study. Inflammatory Bowel Diseases. 31(12). 3363–3369.

Cusato, Jessica, Davide Giuseppe Ribaldone, Alessandra Manca, et al.. (2024). Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. Biomedicines. 12(4). 824–824. 2 indexed citations

Bertani, Lorenzo, Domenico Tricò, Brigida Barberio, et al.. (2024). P965 Ulcerative proctitis treated with biologics: is it too hard to treat?. Journal of Crohn s and Colitis. 18(Supplement_1). i1743–i1743.

Bertani, Lorenzo, et al.. (2024). Specific probiotics and prebiotics to improve the quality of life of patients with chronic irritable bowel syndrome. Minerva Gastroenterology. 70(4). 413–421. 2 indexed citations

Bertin, Luisa, Fabiana Zingone, Andrea Buda, et al.. (2023). Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review. Cancers. 15(15). 3824–3824. 3 indexed citations

Tapete, Gherardo, Lorenzo Bertani, Erica Nicola Lynch, et al.. (2021). Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry. Inflammatory Bowel Diseases. 28(1). 62–69. 27 indexed citations

Bertani, Lorenzo, Domenico Tricò, Federico Zanzi, et al.. (2021). Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis. Nutrients. 13(2). 608–608. 20 indexed citations

Barberio, Brigida, Fabiana Zingone, Antonio Ferronato, et al.. (2021). Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator. Scientific Reports. 11(1). 10368–10368. 28 indexed citations

Bertani, Lorenzo, Domenico Tricò, Daniela Pugliese, et al.. (2020). Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients. Alimentary Pharmacology & Therapeutics. 53(2). 273–280. 17 indexed citations

10.

Bertani, Lorenzo, Gian Paolo Caviglia, Luca Antonioli, et al.. (2020). Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine. 9(5). 1323–1323. 22 indexed citations

11.

Antonioli, Luca, Matteo Fornai, Carolina Pellegrini, et al.. (2020). Inflammatory Bowel Diseases: It's Time for the Adenosine System. Frontiers in Immunology. 11. 1310–1310. 10 indexed citations

12.

Bertani, Lorenzo, Luca Antonioli, Matteo Fornai, et al.. (2020). Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. PubMed. 65(4). 298–308. 11 indexed citations

13.

Bertani, Lorenzo, Giorgia Bodini, M.G. Mumolo, et al.. (2019). Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive Diseases and Sciences. 65(8). 2397–2402. 9 indexed citations

14.

Guidi, Luisa, Daniela Pugliese, Lorenzo Bertani, et al.. (2019). Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European Gastroenterology Journal. 7(9). 1189–1197. 35 indexed citations

15.

Mumolo, M.G., Lorenzo Bertani, Linda Ceccarelli, et al.. (2018). From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology. 24(33). 3681–3694. 133 indexed citations

16.

Cremon, Cesare, Simone Guglielmetti, Giorgio Gargari, et al.. (2017). Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. United European Gastroenterology Journal. 6(4). 604–613. 89 indexed citations

17.

Tenca, Andrea, Nicola de Bortoli, Aurelio Mauro, et al.. (2017). Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. Digestive and Liver Disease. 49(9). 978–983. 14 indexed citations

18.

Martinucci, Irene, Nicola de Bortoli, Salvatore Russo, et al.. (2016). Barrett’s esophagus in 2016: From pathophysiology to treatment. World Journal of Gastrointestinal Pharmacology and Therapeutics. 7(2). 190–190. 14 indexed citations

19.

Bortoli, Nicola de, Irene Martinucci, Radu Țuțuian, et al.. (2015). Esophageal bolus contact time and chemical clearance may differentiate patients with non-erosive reflux disease: an impedance-pH monitoring study. Neurogastroenterology & Motility. 27. 9–10. 1 indexed citations

20.

Bortoli, Nicola de, Irene Martinucci, Edoardo Savarino, et al.. (2015). Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. Digestive and Liver Disease. 47(12). 1027–1032. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact